However, human GBM-derived TGF-β may lead to downregulation of NKG2D receptors on the surface of NK cells and contribute to GBM cell survival, suggesting that blocking TGF-β may be beneficial in the treatment of GBMs (230). The gene discussed is TGFB1; the disease is glioblastoma.